FundedIQ
Agriculture and Farming

Multus: Funding, Investors & Team (Sep 2026)

Various goods made from mammalian cells include tissue-transplants, medications, vaccinations, and disease models. However, the high expense of cultivating cells has turned into a barrier for businesses trying to innovate in the food and healthcare sectors. Currently, these cells are grown using animal-based growth medium. This is not only very pricey, but also of varying quality and was sourced unethically. Most cell culture mediums need the death of young mammals to collect this priceless mixture. We intend to address these issues by developing a novel, affordable, and animal-free growing medium.

www.multus.bio LinkedIn London, United Kingdom 11-50 employees
Agriculture AgTech Biotechnology Food and Beverage Livestock B2B Cellularagriculture Culturemedium
Total raised
$9.7M
Rounds
1
Latest
Series A
Jan 2023

Multus has raised $9.7M across 1 funding round on record, the most recent a Series A of $9.7M announced in Jan 2023.

That round is above the $3.3M median round size for Agriculture and Farming companies tracked on FundedIQ over the last two years.

Multus Company Profile and Key Stats

Total funding raised
$9.7M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$9.7M in Jan 2023
Employees
11-50
reported band
Headquarters
London, United Kingdom

Latest funding round on record: Jan 2023.

Multus Funding Rounds

Date
Round
Amount
Series A
$9.7M

Multus Founders and Leadership Team

Name
Role
Contact
Reka Tron
Founder
Locked

Contact details for the Multus team: 1 of 1 has an email address on file.

Start 14-day free trial →

Multus Funding Compared to Other Agriculture and Farming Startups

Segment
Companies
Median round

Multus' latest round of $9.7M is above the median round in Agriculture and Farming. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Multus in Agriculture and Farming and London

Companies Similar to Multus

Breedr is a productivity and marketing platform that’s transforming the livestock supply-chain.

Series B $27.0M

MoA Technology Limited is a plant genetics company spun out from the University of Oxford. Professor Liam…

Series C $29.7M

Omni is a plant-based pet food company from the UK, that is developing healthy, sustainable food for dogs.

Series A $14.6M

HyveGeo's goal is to contribute to a greener future by implementing technologies that remove carbon dioxide…

Undisclosed round $140k

Sow & Soul is building the decision-making infrastructure for livestock and crop farming. The platform…

Undisclosed round $10k

Cordon Technologies manufactures Cost-effective, environmentally sensitive, vineyard automation solutions.

Seed $1.3M

Equisera engineers circular energy systems that convert biogenic materials and complex wet waste into usable…

Undisclosed round $150k

QuberTech develops biotechnology solutions to create an alternative natural rubber supply chain. The company…

Seed $4.6M

We make real meat, without animals. We produce ethical and sustainable cultivated meat for pets without…

Series A $14.1M

SugaROx develops crop biostimulants to improve crop yield, quality and resilience to climate change. Its…

Series A $3.4M

Oxbury is the UK’s only specialist agricultural bank and the only bank that has a singular focus on the rural…

Undisclosed round $13.4M

Eden Research is the only listed UK-based company focussed upon the development of Biopesticides for…

Undisclosed round $14.5M

Multus Funding FAQs

What does Multus do?

Various goods made from mammalian cells include tissue-transplants, medications, vaccinations, and disease models. However, the high expense of cultivating cells has turned into a barrier for businesses trying to innovate in the food and healthcare sectors. Currently, these cells are grown using animal-based growth medium. This is not only very pricey, but also of varying quality and was sourced unethically. Most cell culture mediums need the death of young mammals to collect this priceless mixture. We intend to address these issues by developing a novel, affordable, and animal-free growing medium.

How much funding has Multus raised?

Multus has raised $9.7M across 1 round on record. The most recent is a Series A of $9.7M announced in Jan 2023.

When did Multus last raise funding?

Multus' most recent funding round on record is a Series A of $9.7M, announced in Jan 2023.

Who founded Multus?

FundedIQ lists Reka Tron (Founder) at Multus.

Where is Multus headquartered?

Multus is based in London, England, United Kingdom.

How many employees does Multus have?

Multus is in the 11-50 employee band.

How does Multus' funding compare to other Agriculture and Farming startups?

Multus' latest round of $9.7M is above the $3.3M median round size for Agriculture and Farming companies on FundedIQ across 1,320 tracked companies over the last two years.

About FundedIQ's Multus Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Multus is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.